JP2016516091A5 - - Google Patents

Download PDF

Info

Publication number
JP2016516091A5
JP2016516091A5 JP2016506585A JP2016506585A JP2016516091A5 JP 2016516091 A5 JP2016516091 A5 JP 2016516091A5 JP 2016506585 A JP2016506585 A JP 2016506585A JP 2016506585 A JP2016506585 A JP 2016506585A JP 2016516091 A5 JP2016516091 A5 JP 2016516091A5
Authority
JP
Japan
Prior art keywords
extract
human
protein
sample
human placenta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016506585A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016516091A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/032696 external-priority patent/WO2014165602A1/en
Publication of JP2016516091A publication Critical patent/JP2016516091A/ja
Publication of JP2016516091A5 publication Critical patent/JP2016516091A5/ja
Pending legal-status Critical Current

Links

JP2016506585A 2013-04-02 2014-04-02 血管新生の誘導および調節のための組成物および方法、ならびに血管新生調節因子を同定する方法およびアッセイ Pending JP2016516091A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361807401P 2013-04-02 2013-04-02
US61/807,401 2013-04-02
PCT/US2014/032696 WO2014165602A1 (en) 2013-04-02 2014-04-02 Compositions and methods for induction and modulation of angiogenesis and methods and assays for identifying angiogenesis modulators

Publications (2)

Publication Number Publication Date
JP2016516091A JP2016516091A (ja) 2016-06-02
JP2016516091A5 true JP2016516091A5 (enExample) 2017-05-18

Family

ID=51621067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016506585A Pending JP2016516091A (ja) 2013-04-02 2014-04-02 血管新生の誘導および調節のための組成物および方法、ならびに血管新生調節因子を同定する方法およびアッセイ

Country Status (8)

Country Link
US (2) US9821013B2 (enExample)
EP (1) EP2981273B1 (enExample)
JP (1) JP2016516091A (enExample)
KR (1) KR20150139569A (enExample)
AU (1) AU2014248198B2 (enExample)
CA (1) CA2908562A1 (enExample)
HK (1) HK1221402A1 (enExample)
WO (1) WO2014165602A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101316602B (zh) 2005-09-27 2015-06-03 组织技术公司 羊膜制品和纯化的组合物及其使用方法
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
EP2717888B1 (en) 2011-06-10 2020-09-09 Tissuetech, Inc. Methods of processing fetal support tissues
JP2016516091A (ja) 2013-04-02 2016-06-02 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 血管新生の誘導および調節のための組成物および方法、ならびに血管新生調節因子を同定する方法およびアッセイ
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
US20160243288A1 (en) 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
TWI720984B (zh) 2015-05-20 2021-03-11 美商帝聖工業公司 用於防止上皮細胞增生及上皮-間質轉移之組合物及方法
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
WO2020036245A1 (ko) * 2018-08-17 2020-02-20 고려대학교 산학협력단 인간 신경줄기세포의 기능강화 및 생산을 위한 태반유래 세포 조건화 배지 및 이의 용도
US20210369630A1 (en) * 2018-10-17 2021-12-02 University Of Florida Research Foundation Magnetically responsive composite microparticles for triggered delivery of biologically active agents
EP3947637A1 (en) 2019-04-04 2022-02-09 THT Biomaterials GmbH A novel human-material-based platform technology for tissue engineering
WO2023038924A1 (en) * 2021-09-07 2023-03-16 Plakous Therapeutics, Inc. Acellular placental therapies

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4829000A (en) * 1985-08-30 1989-05-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Reconstituted basement membrane complex with biological activity
US4994559A (en) 1985-12-17 1991-02-19 Synergen, Inc. Human basic fibroblast growth factor
JP2770926B2 (ja) * 1985-12-17 1998-07-02 サイナーゲン インコーポレーテッド 毛管内皮細胞プロテアーゼ合成、ｄｎａ合成および遊走を促進することの出来るヒト胎盤血管形成誘導因子
JPS63152322A (ja) * 1986-09-30 1988-06-24 Ichimaru Pharcos Co Ltd プラセンタ−組織由来フイブロネクチン含有溶液
CA2005600A1 (en) 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor
AUPM425294A0 (en) * 1994-03-04 1994-03-31 Australian National University, The In-vitro angiogenesis assay
US5770565A (en) 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
JPH0931100A (ja) * 1995-07-24 1997-02-04 Nippon Ham Kk 変性コラーゲン及びその製造方法
CA2375617A1 (en) 1999-06-07 2000-12-14 Edwards Lifesciences Corporation Targeted angiogenesis
US7163681B2 (en) 2000-08-07 2007-01-16 Centocor, Inc. Anti-integrin antibodies, compositions, methods and uses
DE60234163D1 (de) * 2001-01-05 2009-12-10 Viromed Ltd Zusammensetzungen zur gentherapie rheumatoider arthritis, die ein gen, das für ein anti-angiogenes protein oder teile davon kodiert, enthalten
WO2003082305A1 (en) * 2002-04-03 2003-10-09 Naohide Yamashita Drug containing human placenta-origin mesenchymal cells and process for producing vegf using the cells
AU2003237078C1 (en) 2002-04-12 2009-10-08 Celgene Corporation Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
US8940292B2 (en) * 2003-01-28 2015-01-27 Wake Forest University Health Sciences Enhancement of angiogenesis to grafts using cells engineered to produce growth factors
WO2005003317A2 (en) 2003-07-01 2005-01-13 Regents Of The University Of Minnesota Engineered blood vessels
JP2005065661A (ja) * 2003-08-20 2005-03-17 Akihiro Yamaguchi ヒト血管内皮細胞のＶＥＧＦ誘導性活性化及び血管新生におけるＩｄの役割
US7775965B2 (en) 2004-03-09 2010-08-17 The Board Of Regents Of The University Of Oklahoma Decellularized grafts from umbilical cord vessels and process for preparing and using same
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
CN101316602B (zh) * 2005-09-27 2015-06-03 组织技术公司 羊膜制品和纯化的组合物及其使用方法
US8003388B2 (en) * 2006-03-24 2011-08-23 Nortis, Inc. Method for creating perfusable microvessel systems
WO2008042441A1 (en) 2006-10-03 2008-04-10 Anthrogenesis Corporation Use of umbilical cord biomaterial for ocular surgery
CA2700613C (en) 2007-09-26 2022-09-20 Celgene Cellular Therapeutics Angiogenic cells from human placental perfusate
WO2009100128A1 (en) * 2008-02-04 2009-08-13 Massachusetts Institute Of Technology Particulate delivery vehicles for embryoid bodies
SG188918A1 (enExample) * 2008-03-17 2013-04-30 Agency Science Tech & Res
US8685634B2 (en) * 2009-03-06 2014-04-01 University of Pittsburgh—of the Commonwealth System of Higher Education Neural scaffolds
CA2769038A1 (en) 2009-07-31 2011-02-03 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Antiangiogenic small molecules and methods of use
KR101118017B1 (ko) 2009-09-04 2012-02-24 (주)차바이오앤디오스텍 태반 추출물을 제조하는 방법 및 태반 추출물
CN102822521B (zh) * 2010-03-30 2016-01-27 西门子公司 具有间接蒸发的太阳能热发电站和运行这种太阳能热发电站的方法
KR20140071813A (ko) 2012-12-04 2014-06-12 삼성전자주식회사 파이버 상에 형성된 저항성 메모리 소자 및 그 제종 방법
JP2016516091A (ja) 2013-04-02 2016-06-02 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 血管新生の誘導および調節のための組成物および方法、ならびに血管新生調節因子を同定する方法およびアッセイ

Similar Documents

Publication Publication Date Title
JP6712016B2 (ja) 三次元組織体及びその製造方法、並びに、三次元組織体の形成剤
Jedrzejczak et al. Bovine mammary epithelial cell cultures for the study of mammary gland functions: Jedrzejczak and Szatkowska
CN102083962B (zh) 生物体内功能性细胞的高效采集方法
Dohle et al. Macrophage-mediated angiogenic activation of outgrowth endothelial cells in co-culture with primary osteoblasts
Li et al. HIMF deletion ameliorates acute myocardial ischemic injury by promoting macrophage transformation to reparative subtype
CN111868231B (zh) 外胚层间充质干细胞及其产生方法
CN105518126B (zh) 根据细胞尺寸来培养间充质干细胞的方法
JP2020525003A (ja) 腎臓病治療のための免疫特権を有する生物活性腎細胞
Kanda et al. Deterministic encapsulation of human cardiac stem cells in variable composition nanoporous gel cocoons to enhance therapeutic repair of injured myocardium
Wang et al. Impact of fibronectin knockout on proliferation and differentiation of human infrapatellar fat pad-derived stem cells
JP2017536826A5 (enExample)
RU2018105986A (ru) Сконструированные эндотелиальные клетки, экспрессирующие фактор транскрипции ets
WO2014165602A1 (en) Compositions and methods for induction and modulation of angiogenesis and methods and assays for identifying angiogenesis modulators
KR101562366B1 (ko) 메타크릴레이트화된 젤라틴을 포함하는, 심근세포분화 유도용 세포 지지체
CN113106059A (zh) 一种高迁徙间充质干细胞及其制备方法和应用
Govoni et al. An innovative stand‐alone bioreactor for the highly reproducible transfer of cyclic mechanical stretch to stem cells cultured in a 3D scaffold
Fratini et al. Endothelial differentiation of canine yolk sac cells transduced with VEGF
Zarychta-Wiśniewska et al. The influence of cell source and donor age on the tenogenic potential and chemokine secretion of human mesenchymal stromal cells
Lu et al. PAARH promotes M2 macrophage polarization and immune evasion of liver cancer cells through VEGF protein
Liu et al. Single-cell transcriptomics identifies PDGFRA+ progenitors orchestrating angiogenesis and periodontal tissue regeneration
Pan et al. Transplantation of induced mesenchymal stem cells for treating chronic renal insufficiency
Rajendran et al. Engineering three-dimensional spheroid culture for enrichment of proangiogenic miRNAs in umbilical cord mesenchymal stem cells and promotion of angiogenesis
CN111690686B (zh) 一种miRNA高表达在促进脐带间充质干细胞体外增殖和成骨分化方面的应用
JP2013500003A5 (enExample)
Pozzobon et al. Alveolar rhabdomyosarcoma decellularization